Drugs / Td
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00553228 Comparator | Nov 2007 → Dec 2015 | — | Scott Halperin | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Td | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00553228 ↗ |
| Modality | Vaccine | “A total of 273 women received either Tdap or tetanus-diphtheria (Td) vaccine in the third trimester” PMID 30010773 ↗ Sep 2018 |
| Route | Intramuscular | “0.5 mL IM once at visit #2” NCT00553228 ↗ |